top
Search terms
Results 1 - 5 of 5 - ordered by :
Epeuropace

When a clinician has to decide on use of antithrombotic drugs in the setting of a patient affected by atrial fibrillation (AF) experiencing an acute coronary syndrome (ACS), the difficult task is ...

Europace, Editorial, Giuseppe Boriani, Deirdre A. Lane, Stephan Windecker, Kurt Huber, Paulus Kirchhof, Gregory Y.H. Lip

Date : 01/09/2015
Ehjournal

Strategies for managing these patients using the newer factor-specific oral anticoagulants are somewhat limited, as these patients represent a small fraction of the overall cohorts studied and only ...

European Heart Journal, Murphy, Sabina A., Giugliano, Robert P.

Date : 21/01/2014
Ehjournal

Strategies for managing these patients using the newer factor-specific oral anticoagulants are somewhat limited, as these patients represent a small fraction of the overall cohorts studied and only ...

European Heart Journal, Murphy, Sabina A., Giugliano, Robert P.

Date : 21/01/2014
Escardio

Sophia Antipolis, 9 January 2012: A registry -which includes every patient in Sweden having percutaneous coronary intervention (PCI) for the treatment of acute and stable coronary artery disease- has ...

Date : 06/01/2012
Escardio

Stockholm, Sweden, 29 August: Antithrombotic therapy using antiplatelet and anticoagulant agents is the cornerstone of treatment for acute and chronic coronary artery disease (CAD), yet it is also ...

Date : 29/08/2010